ATE395055T1 - Pharmazeutische zusammensetzung zur behandlung von hyperhomocysteinämie - Google Patents

Pharmazeutische zusammensetzung zur behandlung von hyperhomocysteinämie

Info

Publication number
ATE395055T1
ATE395055T1 AT04104599T AT04104599T ATE395055T1 AT E395055 T1 ATE395055 T1 AT E395055T1 AT 04104599 T AT04104599 T AT 04104599T AT 04104599 T AT04104599 T AT 04104599T AT E395055 T1 ATE395055 T1 AT E395055T1
Authority
AT
Austria
Prior art keywords
hyperhomocysteinemia
treatment
pharmaceutical composition
disclosed
relates
Prior art date
Application number
AT04104599T
Other languages
English (en)
Inventor
Sergio Anzalone
Original Assignee
Medosan Ind Biochimi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medosan Ind Biochimi filed Critical Medosan Ind Biochimi
Application granted granted Critical
Publication of ATE395055T1 publication Critical patent/ATE395055T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7135—Compounds containing heavy metals
    • A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT04104599T 2003-09-26 2004-09-22 Pharmazeutische zusammensetzung zur behandlung von hyperhomocysteinämie ATE395055T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT000442A ITRM20030442A1 (it) 2003-09-26 2003-09-26 Composizione farmaceutica (stressen) per il trattamento di iperomocisteinemia.

Publications (1)

Publication Number Publication Date
ATE395055T1 true ATE395055T1 (de) 2008-05-15

Family

ID=30131588

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04104599T ATE395055T1 (de) 2003-09-26 2004-09-22 Pharmazeutische zusammensetzung zur behandlung von hyperhomocysteinämie

Country Status (4)

Country Link
EP (1) EP1518554B1 (de)
AT (1) ATE395055T1 (de)
DE (1) DE602004013695D1 (de)
IT (1) ITRM20030442A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20110847A1 (it) * 2011-05-13 2012-11-14 Soldato Piero Del Uso di un composto solforato per il trattamento di iperomocisteinemia e patologie correlate
CN105560264A (zh) * 2016-03-11 2016-05-11 广东伊茗药业有限公司 一种含腺苷钴胺的组合物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6054128A (en) * 1997-09-29 2000-04-25 Wakat; Diane Dietary supplements for the cardiovascular system
DE10004651A1 (de) * 2000-02-03 2001-08-16 Jutta Dierkes Kombination von blutdrucksenkenden Wirkstoffen mit Wirkstoffen, die den Homocysteinspiegel zu senken vermögen
US20030054978A1 (en) * 2001-08-31 2003-03-20 Babish John G. Arginine compositions for coordinate modification of multiple cardiovascular risk factors
DE10206159A1 (de) * 2002-02-14 2003-08-28 Kosmas Kg Mittel, enthaltend Folsäure, Vitamin B6 und Vitamin B12, und dessen Verwendung

Also Published As

Publication number Publication date
DE602004013695D1 (de) 2008-06-26
ITRM20030442A1 (it) 2005-03-27
EP1518554A1 (de) 2005-03-30
EP1518554B1 (de) 2008-05-14
ITRM20030442A0 (it) 2003-09-26

Similar Documents

Publication Publication Date Title
ATE495739T1 (de) Pharmazeutische zusammensetzungen und verfahren zur verwendung von levodopa und carbidopa
BR0316350A (pt) Diaminotriazóis úteis como inibidores de proteìna cinases
ATE484494T1 (de) Substituierte indolderivate für eine pharmazeutische zusammensetzung zur behandlung von atemwegserkrankungen
ATE497495T1 (de) Zur behandlung von neoplastischen erkrankungen, entzündlichen erkrankungen und erkrankungen des immunsystems geeignete 2,4- di(phenylamino)pyrimidine
EA200700860A1 (ru) (бифенил)карбоновые кислоты и их производные
UY27755A1 (es) Nuevas composiciones farmacéuticas basadas en anticolinérgicos e inhibidores.
EA200401114A2 (ru) Замещённые гидроксиэтиламины
ATE390407T1 (de) Phenethanolamin-derivate zur behandlung von atemwegserkrankungen
EA200500169A1 (ru) Замещенные производные 1,3-дифенилпроп-2-ен-1-она, получение и применение
DE60232251D1 (de) Pharmazeutische zusammensetzungen zur behandlung von asthma
ATE432072T1 (de) Verwendung von adapalen zur behandlung dermatologischer erkrankungen
ATE521357T1 (de) Verfahren zur behandlung von hepatitis
DK1594833T3 (da) 1-phenylalkancarboxylsyrederivater til behandling af neurodegenerative sygdomme
EA200401365A1 (ru) Способы лечения илеуса
ATE350377T1 (de) Substituierte 3-pyrrolidin-indol-derivate
EA200600588A1 (ru) Соединения, содержащие галоидалкил, как ингибиторы цистеиновых протеаз
DE60318839D1 (de) 2,6-chinolinyl- und 2,6-naphthylderivate und deren verwendungen zur behandlung von vla-4 bezogenen krankheiten
UY28098A1 (es) Derivados de anilinopirazol útiles en el tratamiento de la diabetes
DE60233433D1 (de) PHARMAZEUTISCHE ZUBEREITUNG enthaltend ein Catechin, Ascorbinsäure, Prolin und Lysin ZUR BEHANDLUNG VON NEOPLASTISCHEN KRANKHEITEN
DE602004017326D1 (de) Tetrahydrocarbazolderivate und deren pharmazeutische verwendung
ATE548035T1 (de) Formulierungen zur behandlung von lipoprotein- anormalitäten mit einem statin- und einem methylnicotinamid-derivat
ATE524181T1 (de) Verwendung von 1,4-bis (3-aminoalkyl) piperazin- derivaten bei der behandlung von neurodegenerativen erkrankungen
ATE504580T1 (de) Malonsäureamidderivate als inhibitoren von g- sekretase zur behandlung von alzheimer-krankheit
EA200601288A1 (ru) Производные 1,3-дифенилпроп-2-ен-1-она, способ их получения и применение
EA200700407A1 (ru) Производные хиназолина и их использования при лечении тромбоцитемии

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties